Navigation Links
Senesco Chooses VGXI to Produce Factor 5A Plasmid
Date:7/3/2008

NEW BRUNSWICK, N.J., July 3 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (Amex: SNT) announced today that it has contracted with VGXI, Inc. (The Woodlands, TX) ("VGXI") to supply the plasmid portion of the Company's combination therapy consisting of the Factor 5A gene and siRNA against Factor 5A.

Senesco has previously reported positive preclinical in vivo results using its combination siRNA and plasmid against subcutaneous multiple myeloma tumors in immunodeficient mice. The Factor 5A plasmid being produced by VGXI, as Senesco's preclinical data has shown, should cause cancer cells to enter apoptosis, or programmed cell death.

"VGXI's manufacturing and technical expertise in producing plasmids for Senesco's planned toxicology study and ultimately our clinical trial led us to choose them. We are pleased to be working with a company that has such an outstanding reputation in the field," commented Bruce Galton, Senesco's President and CEO.

Henry Hebel, Vice President of Operations for VGXI said, "We believe that our ability to quickly supply the preclinical and clinical needs of our clients will allow Senesco to rapidly advance their programs. We are continuing to expand our collaborative development services to meet the growing needs for a wide variety of plasmid based products."

About VGXI Inc.

VGXI Inc. is a leading manufacturer of DNA plasmids, and its cGMP and non-cGMP products have passed rigorous reviews by several international regulatory agencies. VGXI offers a wide variety of contract manufacturing services to outside client organizations. The Company's cGMP manufacturing facility in The Woodlands, Texas is a flexible, purpose-built facility used for research,
'/>"/>

SOURCE Senesco Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
2. Senescos Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences
3. Senesco Technologies Initiates Preclinical Studies for Cancer Target
4. OncoMed Chooses SynCo Bio Partners to Fill and Finish its Lead Antibody
5. Sequential R-CHOP and Ibritumomab Tiuxetan (Zevalin(R)) Regimen Produces Impressive Survival Rates in High Risk Elderly Patients With Untreated Aggressive Diffuse Large B-cell Lymphoma
6. Infant Vaccines Produce Autism Symptoms in New Primate Study by University of Pittsburgh Scientists
7. New Study Shows Proprietary Canola Extract, Dermytol(TM), Produces Pronounced Decrease in Malignant Melanoma Tumor Volume
8. Fludarabine, Mitoxantrone and Zevalin(R) Produces 96% Complete Remission Rate in First-Line Treatment of Patients with Follicular Non-Hodgkins Lymphoma
9. Zevalin(R) Combined With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation (ASCT) Produces High Overall Survival and Progression-Free Survival Rates in Patients With Relapsed Non-Hodgkins Lymphoma
10. R-CALF United Stockgrowers of America: Fighting for the U.S. Cattle Producer
11. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... , NEW YORK, Dec. 3 Guidepo... today announced the launch of their Sleep Apnea T...onitors and projects trends and market share in th...pnea Tracker captures actual patient usage for 87 ...ed States from 15 different equipment providers go...
(Date:12/3/2009)... , DOYLESTOWN, Pa., Dec. 3 /PRNewswire-F...uigley Corporation, (Nasdaq: QGLY ) www.quigleyc...ted its evaluation of its opportunities to develop...has concluded that it is in its best interests to ...ce, which may include but are not limited to its C...
(Date:12/3/2009)... , FORT WORTH, Texas, Dec. 3 /PRNewsw... Inc. (OTC Bulletin Board: WNDM), a rapidly growin...d today an agreement with the Health Industry Repr...clusive independent sales and marketing representa...; product within the U.S. ,, HIRA will marke...
Breaking Medicine Technology:Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Cadus Reports Third Quarter 2009 Results 14855 1Cadus Reports Third Quarter 2009 Results 14855 2Cadus Reports Third Quarter 2009 Results 14855 3Cadus Reports Third Quarter 2009 Results 14855 4Cadus Reports Third Quarter 2009 Results 14855 5New Data 3A Cholesterol Management Analysis of Upsher Smiths Slo Niacin 28R 29 Tablets in Combination with Lipitor 28R 29 6301 1New Data 3A Cholesterol Management Analysis of Upsher Smiths Slo Niacin 28R 29 Tablets in Combination with Lipitor 28R 29 6301 2New Data 3A Cholesterol Management Analysis of Upsher Smiths Slo Niacin 28R 29 Tablets in Combination with Lipitor 28R 29 6301 3New Data 3A Cholesterol Management Analysis of Upsher Smiths Slo Niacin 28R 29 Tablets in Combination with Lipitor 28R 29 6301 4Indiana University receives NIH grant to improve health care in East Africa 61442 1Indiana University receives NIH grant to improve health care in East Africa 61442 2Indiana University receives NIH grant to improve health care in East Africa 61442 3
(Date:12/4/2009)..., Dec. 4 Thousands of KPMG LLP emp...nwide today, to participate in a community service...firm,s support for literacy with charitable giving...irm,s long history of volunteerism. Instead of hol... of caring to brighten the holidays for some child...
(Date:12/4/2009)... Dec. 4 The American As...SA) applauds the Senate for ensuring that the Com...isions remain in the final health reform legislati...ing support to elders, people with disabilities an...ass a health care reform bill that will make it af...
(Date:12/4/2009)...ADISON HEIGHTS, Mich., Dec. 4 The ... of BetterInvesting Magazine today announced Al..."Stock to Study" and C.R. Bard, Inc. (NYSE: BC...nvestors, informational and educational use. ,,...pportunities involving its flagship drug Botox and...
(Date:12/4/2009)...N, Dec. 4 In response t...ncy,s (DEA) classification of boldione, desoxymeth...one as "anabolic steroids", under the Controlled S...and CEO of the Natural Products Association (NPA),...nting retailers and manufacturers of dietary suppl...
(Date:12/4/2009)... scientists at Johns Hopkins publishing in the Dec...in made by a gene called "Twist" may be the prover... cells that drive aggressive, metastatic breast ca...on recent work suggesting that it is a relatively ...drives breast cancer, scientists have surmised tha...
Breaking Medicine News(10 mins):Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3
... Providence, RI Using a new tool designed to mea...pical gels designed to prevent the sexual transmis...nd Brown University found that women who have used...safe and effective microbicide has not been identi...
...eaturing Emmy award-winning composer, Yale profess..., March 3 Gary Malkin, Emmy,award-winning compose...,Association of Professional Chaplains Annual Conf...ing is,the life work of our member chaplains," say...
...cyou offers a free online healthcare video and inf...munity, CHARLESTON, S.C., March 3 Today Benefitf...ta site icyou ( http://www.icyou.com ),which merge...althcare videos, as well as communicate with other...
... EVANSTON, Ill. --- Although researchers have lon...es than boys, until now no one has clearly provide...fferences. , For the first time -- and in unambi... harder in girls than in boys during language task...
...tudy says breathing-related problems more likely i...thDay News) -- Obese children are much more likely...ated problems during surgery, says a University of...ctive, non-cardiac surgery, found that obese child...
...OLMDEL, N.J., March 3 Sparta Systems, Inc. (Spart...r in enterprise quality and,compliance management ...leading developer and manufacturer of sterile inje... complexity of the pharmaceutical field, companies...
Other Medicine News:Health News:Researchers develop new tool to predict who will use microbicides 2Health News:Researchers develop new tool to predict who will use microbicides 3Health News:Spiritual Health Experts Speak at Chaplains Conference in Pittsburgh March 8-12 2Health News:Benefitfocus(R) Healthcare Video Portal Merges Community with Credibility 2Health News:Gender differences in language appear biological 2Health News:Gender differences in language appear biological 3Health News:Obese Children Face More Complications During Surgery 2Health News:Bioniche Pharma Chooses TrackWise for its Deviation Control Solution 2
...ew solid-state IRIS Medical IQ 810 infrared diode ... disorders and glaucoma. The Companys top-of-the-l...nological innovation and is designed to perform tr...MIP) procedures in the office and operating room s...
...oconus detected early is best corrected with GP le...be present, GP lenses will help the patient adapt ...istortions of the corneal surface and provide impr...llenge for even the most experienced practitioner....
...ded as "a quantum leap forward in the evolution of... Rose K lens has become the world's most frequentl...keratoconus.,Unlike traditional contact lenses, t...t lens closely mimics the cone like shape of the c...
...odel 614B is our most affordable basic centrifuge.... office. The 614 is also the quietest small lab ce...ill spin up to six (6) test tubes up to 15ml (up t...and is UL/CSA compliant. 30 MINUTE TIMER: Mecha...
Medicine Products: